Sanyou Bio Closes Nearly RMB 100M Series C from Zero2IPO Industrial Fund
Sanyou Bio raised nearly RMB 100 million in a Series C solely from Zero2IPO’s industrial fund (about RMB 300 million cumulative), accelerating an AI-driven innovative-drug R&D and translation stack. More: AI Investment.
© 版权声明
The copyright of the article belongs to the author, please do not reprint without permission.